Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin

Background Genome-wide association studies have identified a plethora of risk genes for both Crohn’s disease (CD) and ankylosing spondylitis (AS). A subset of genes found to be risk factors for CD have also been found to be risk factors for AS. The objective of our study was to assess whether CD ris...

Full description

Bibliographic Details
Main Authors: Rebecca L. Roberts, Mary C. Wallace, Andrew A. Harrison, Douglas White, Nicola Dalbeth, Lisa K. Stamp, Daniel Ching, John Highton, Tony R. Merriman, Philip C. Robinson, Matthew A. Brown, Simon M. Stebbings
Format: Article
Language:English
Published: PeerJ Inc. 2018-06-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/5088.pdf
id doaj-c42e3df590424d19a6dc945a8da95468
record_format Article
spelling doaj-c42e3df590424d19a6dc945a8da954682020-11-24T23:07:49ZengPeerJ Inc.PeerJ2167-83592018-06-016e508810.7717/peerj.5088Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectinRebecca L. Roberts0Mary C. Wallace1Andrew A. Harrison2Douglas White3Nicola Dalbeth4Lisa K. Stamp5Daniel Ching6John Highton7Tony R. Merriman8Philip C. Robinson9Matthew A. Brown10Simon M. Stebbings11Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandDepartment of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandDepartment of Medicine, University of Otago Wellington, Wellington, New ZealandDepartment of Rheumatology, Waikato Clinical School, Waikato Hospital, Hamilton, New ZealandDepartment of Medicine, University of Auckland, Auckland, New ZealandDepartment of Medicine, University of Otago Christchurch, Christchurch, New ZealandDepartment of Rheumatology, Timaru Hospital, Timaru, New ZealandDepartment of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandDepartment of Biochemistry, University of Otago, Dunedin, New ZealandSchool of Medicine, Faculty of Medicine and Biomedical Sciences, University of Queensland, Brisbane, QLD, AustraliaInstitute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, QLD, AustraliaDepartment of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandBackground Genome-wide association studies have identified a plethora of risk genes for both Crohn’s disease (CD) and ankylosing spondylitis (AS). A subset of genes found to be risk factors for CD have also been found to be risk factors for AS. The objective of our study was to assess whether CD risk genes were associated with non-invasive clinical markers of gut inflammation in patients with AS, indicating a potential subset of patients with clinical as well as genetic overlap. Methods A total of 308 Caucasian patients who fulfilled the modified New York Criteria for AS, were assessed for bowel symptoms using the Dudley Inflammatory Bowel Symptom Questionnaire (DISQ). Of these patients, 157 also had faecal calprotectin measured. All AS patients and 568 healthy controls were genotyped for 10 CD risk loci using predesigned single nucleotide polymorphism (SNP) genotyping assays. Chi-square analysis was used to test for association between genotype and DISQ score and faecal calprotectin level. Results The minor allele of two SNPs, one in chromosome region 1q32 SNP (rs11584383), and one in the gene coding for IL23R (rs11209026) conferred protection against AS. Only the association of 1q32 remained significant after Bonferroni correction for multiple testing. Stratification by DISQ score and faecal calprotectin did not influence the association of 1q32 with AS. Conclusion In patients with AS, the association of the CD 1q32 SNP was independent of non-invasive markers of bowel inflammation. Other CD related SNPs were not found have a significant association with AS.https://peerj.com/articles/5088.pdfDudley Inflammatory Bowel Symptom QuestionnaireAxial inflammationCrohn’s diseaseKinesin Family Member 21BBowel inflammation
collection DOAJ
language English
format Article
sources DOAJ
author Rebecca L. Roberts
Mary C. Wallace
Andrew A. Harrison
Douglas White
Nicola Dalbeth
Lisa K. Stamp
Daniel Ching
John Highton
Tony R. Merriman
Philip C. Robinson
Matthew A. Brown
Simon M. Stebbings
spellingShingle Rebecca L. Roberts
Mary C. Wallace
Andrew A. Harrison
Douglas White
Nicola Dalbeth
Lisa K. Stamp
Daniel Ching
John Highton
Tony R. Merriman
Philip C. Robinson
Matthew A. Brown
Simon M. Stebbings
Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
PeerJ
Dudley Inflammatory Bowel Symptom Questionnaire
Axial inflammation
Crohn’s disease
Kinesin Family Member 21B
Bowel inflammation
author_facet Rebecca L. Roberts
Mary C. Wallace
Andrew A. Harrison
Douglas White
Nicola Dalbeth
Lisa K. Stamp
Daniel Ching
John Highton
Tony R. Merriman
Philip C. Robinson
Matthew A. Brown
Simon M. Stebbings
author_sort Rebecca L. Roberts
title Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
title_short Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
title_full Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
title_fullStr Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
title_full_unstemmed Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
title_sort association of crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
publisher PeerJ Inc.
series PeerJ
issn 2167-8359
publishDate 2018-06-01
description Background Genome-wide association studies have identified a plethora of risk genes for both Crohn’s disease (CD) and ankylosing spondylitis (AS). A subset of genes found to be risk factors for CD have also been found to be risk factors for AS. The objective of our study was to assess whether CD risk genes were associated with non-invasive clinical markers of gut inflammation in patients with AS, indicating a potential subset of patients with clinical as well as genetic overlap. Methods A total of 308 Caucasian patients who fulfilled the modified New York Criteria for AS, were assessed for bowel symptoms using the Dudley Inflammatory Bowel Symptom Questionnaire (DISQ). Of these patients, 157 also had faecal calprotectin measured. All AS patients and 568 healthy controls were genotyped for 10 CD risk loci using predesigned single nucleotide polymorphism (SNP) genotyping assays. Chi-square analysis was used to test for association between genotype and DISQ score and faecal calprotectin level. Results The minor allele of two SNPs, one in chromosome region 1q32 SNP (rs11584383), and one in the gene coding for IL23R (rs11209026) conferred protection against AS. Only the association of 1q32 remained significant after Bonferroni correction for multiple testing. Stratification by DISQ score and faecal calprotectin did not influence the association of 1q32 with AS. Conclusion In patients with AS, the association of the CD 1q32 SNP was independent of non-invasive markers of bowel inflammation. Other CD related SNPs were not found have a significant association with AS.
topic Dudley Inflammatory Bowel Symptom Questionnaire
Axial inflammation
Crohn’s disease
Kinesin Family Member 21B
Bowel inflammation
url https://peerj.com/articles/5088.pdf
work_keys_str_mv AT rebeccalroberts associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT marycwallace associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT andrewaharrison associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT douglaswhite associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT nicoladalbeth associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT lisakstamp associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT danielching associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT johnhighton associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT tonyrmerriman associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT philipcrobinson associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT matthewabrown associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
AT simonmstebbings associationofcrohnsdiseaserelatedchromosome1q32withankylosingspondylitisisindependentofbowelsymptomsandfaecalcalprotectin
_version_ 1725616873662316544